SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 13, 2004 DIALYSIS CORPORATION OF AMERICA (Exact name of registrant as specified in its charter) Florida 0-8527 59-1757642 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 1344 Ashton Road, Hanover, Maryland 21076 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (410) 694-0500 Item 5. Other Events and Required FD Disclosure The board of directors of the company, on January 13, 2004, declared a two-for-one stock split with respect to the 3,968,772 outstanding shares of common stock. The record date for shareholders to be entitled to participate in the stock split is January 28, 2004. The distribution date for the issuance of the new common stock certificates is February 9, 2004. The split will increase the outstanding shares to 7,937,544 shares. There will be no modifications to the authorized capital or the par value of the common stock, which shall remain at $.01 par per share as a result of the split. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. (a) Financial Statements of Businesses Acquired Not applicable (b) Pro Forma Financial Information Not applicable (c) Exhibits (99) Additional Exhibits Press Release dated January 16, 2004 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DIALYSIS CORPORATION OF AMERICA /s/ Stephen W. Everett By--------------------------------- STEPHEN W. EVERETT, Chief Executive Officer and President Dated: January 16, 2004